Bosutinib-[d3]

Bosutinib-[d3], is the labelled analogue of Bosutinib. Bosutinib is a small molecule BCR-ABL and src tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia.
Supplier BOC Sciences
Product # BLP-002089
Pricing Inquire
Cas 1613270-48-6
Molecular Weight 533.46
Molecular Formula C26H26D3Cl2N5O3
Feedback